Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 22743731)

1.

Successful liver transplantation with continued dual antiplatelet therapy.

Spieker H, Benckert C, Quante M, Thelen A, Gaebelein G, Kaisers U, Jonas S.

Ann Transplant. 2012 Apr-Jun;17(2):127-30.

PMID:
22743731
2.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Review.

PMID:
18319394
3.

Coronary artery stents and antiplatelet therapy in patients with cirrhosis.

Russo MW, Pierson J, Narang T, Montegudo A, Eskind L, Gulati S.

J Clin Gastroenterol. 2012 Apr;46(4):339-44. doi: 10.1097/MCG.0b013e3182371258.

PMID:
22105182
4.

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA.

N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.

5.

Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.

Zeymer U, Gitt A, J√ľnger C, Bauer T, Heer T, Koeth O, Mark B, Zahn R, Senges J, Gottwik M.

Thromb Haemost. 2008 Jan;99(1):155-60. doi: 10.1160/TH07-09-0556.

PMID:
18217148
6.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

7.

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.

Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):395-405. doi: 10.1002/ccd.23337. Epub 2012 Jan 10.

PMID:
22109961
8.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
9.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

10.

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ; CREDO Investigators.

Am Heart J. 2009 Feb;157(2):369-74. doi: 10.1016/j.ahj.2008.09.011. Epub 2008 Nov 1.

PMID:
19185647
11.

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.

Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK.

J Invasive Cardiol. 2006 Apr;18(4):162-4.

PMID:
16729401
12.

Dual antiplatelet agent-induced spontaneous liver hematoma.

Darwish OS, Iqbal E.

Ann Pharmacother. 2012 Nov;46(11):e33. doi: 10.1345/aph.1R183. Epub 2012 Oct 16.

PMID:
23073305
13.

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators.

N Engl J Med. 2006 Apr 20;354(16):1706-17. Epub 2006 Mar 12.

14.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
15.

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.

Guthrie R.

Adv Ther. 2011 Jun;28(6):473-82. doi: 10.1007/s12325-011-0026-0. Epub 2011 May 3. Review.

PMID:
21547541
16.

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.

Am J Cardiol. 2008 Dec 15;102(12):1618-23. doi: 10.1016/j.amjcard.2008.08.021. Epub 2008 Sep 24.

PMID:
19064015
17.

Safety of dental extractions during uninterrupted single or dual antiplatelet treatment.

Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G.

Am J Cardiol. 2011 Oct 1;108(7):964-7. doi: 10.1016/j.amjcard.2011.05.029. Epub 2011 Jul 23.

PMID:
21784392
18.

Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?

Diener HC.

Int J Stroke. 2006 Feb;1(1):4-8. doi: 10.1111/j.1747-4949.2005.00016.x.

PMID:
18706062
19.

Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?

Mohler ER 3rd.

Catheter Cardiovasc Interv. 2009 Jul 1;74 Suppl 1:S1-6. doi: 10.1002/ccd.21995. Review.

PMID:
19213065
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk